SARS

Woman in face shield and blue gown taking cotton swab of patient's mouth while patient sits inside of car

What You Should Know About New Omicron Subvariants

Natalia Mesa, PhD | May 17, 2022 | 6 min read

The presence and spread of new, more-infectious and immune-evading variants show that the coronavirus is not done mutating.

sign reading "bio-security precautions, no unauthorized personnel"

Opinion: Coronavirus and Regulating Access to High-Risk Pathogens

Michael Parker, Shreya Kalra, and Bryce Kassalow | Feb 10, 2022 | 10+ min read

Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.

Beyond Acute Respiration: SARS-CoV-2's Effects on Long-Term Physiology

The Scientist’s Creative Services Team | 1 min read

John Connolly and Masataka Nishiga discuss the effects of SARS-CoV-2 on the neurological and cardiovascular systems.

CDC Pathology Investigator Dies Unexpectedly at 65

Jef Akst | Nov 23, 2021 | 2 min read

Sherif Zaki worked at the Centers for Disease Control and Prevention for more than 30 years, and was renowned for uncovering crucial intel on various outbreak-causing scourges, from Ebola and Zika to SARS and influenza.

close-up of empty vaccine vials in a factory

The Quest for a Universal Coronavirus Vaccine

Diana Kwon | Jun 29, 2021 | 8 min read

Scientists are on the hunt for a shot that will protect against not only SARS-CoV-2, but other members of its family that may emerge in the future.

First Responders: SARS-CoV-2 and the Immune System

The Scientist’s Creative Services Team | 1 min read

Angela Rasmussen and Ya-Chi Ho explore the positive and negative aspects of the host immune response to SARS-CoV-2 infection and discuss how this knowledge influences therapeutic benefits.

The Psychology of Panic

Bob Grant | Jun 1, 2021 | 3 min read

The recent news of consumers hoarding gasoline in the face of a brief closure of one of the world’s biggest petroleum pipelines is just the latest episode of panic buying since the COVID-19 pandemic started.

Contributors

The Scientist Staff | Jun 1, 2021 | 4 min read

Meet some of the people featured in the June 2021 issue of The Scientist.

Tailor-Made: Empowering SARS-CoV-2 Researchers Worldwide

The Scientist’s Creative Services Team | 2 min read

Arbor Biosciences is offering free SARS-CoV-2 myBaits kits to all researchers.

Opinion: Comparing Coronaviruses

Nicola Petrosillo | Jun 1, 2021 | 4 min read

In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.

Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show

Ashley Yeager | Nov 23, 2020 | 4 min read

Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.

Q&A: COVID-19 Infectiousness Peaks Early in Sickness, Study Shows

Max Kozlov | Nov 23, 2020 | 6 min read

Patients’ viral loads are highest within five days of their first symptoms, emphasizing the need to isolate early to prevent transmission.

SARS-CoV-2 Exits Cells Via Lysosomes

Abby Olena, PhD | Nov 13, 2020 | 4 min read

A study finds that β-coronaviruses don’t use the normal secretory pathway, a possible explanation for some aspects of COVID-19 pathology.

Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases

Anthony King | Nov 11, 2020 | 5 min read

Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses.

The Many Model Systems of COVID-19

Abby Olena, PhD | Nov 4, 2020 | 7 min read

Researchers turn to familiar model animals, along with some fresh strategies, to develop countermeasures against SARS-CoV-2 and investigate the biology of infection.